Humana (HUM)
(Delayed Data from NYSE)
$279.45 USD
-37.29 (-11.77%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $278.50 -0.95 (-0.34%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$279.45 USD
-37.29 (-11.77%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $278.50 -0.95 (-0.34%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Zacks News
4 Reasons to Stay Away from Mednax (MD) Now
by Zacks Equity Research
Mednax (MD) is suffering from subdued pace of birth across the country, which has slowed the growth of one of its core businesses, neonatology.
Humana (HUM) Up 2.7% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Humana (HUM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc Hits 52-Week High on Strong Results, Client Wins
by Zacks Equity Research
Teladoc's (TDOC) 52-week high is believed to have been driven by the company's better-than-expected first-quarter earnings along with the recent news of expansion of its telehealth offerings in Texas.
Top Stock Reports for Eli Lily, HSBC, Marriott & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly (LLY), HSBC (HSBC) and Marriott (MAR).
Buy these 5 Low Leverage Stocks to Keep your Portfolio Safe
by Zacks Equity Research
The U.S. stock market recovered last Friday, driven by positive market sentiment with two significant data points for the month of May expected shortly. The consumer confidence figures will be released today while the jobs report is due on Friday.
UnitedHealth's (UNH) Business Unit Collaborates with Merck
by Zacks Equity Research
UnitedHealth Group, Inc.???s (UNH) information and technology-enabled health services business "Optum" recently announced its collaboration with Merck & Co. Inc (MRK).
The Zacks Analyst Blog Highlights: Humana, UnitedHealth Group, Tenet Healthcare, LifePoint Health and Community Health Systems
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Humana, UnitedHealth Group, Tenet Healthcare, LifePoint Health and Community Health Systems
Insurers & Hospital Stocks in Focus on CBO Report on Trumpcare
by Arpita Dutt
According to the CBO, 23M people would lose health coverage in 2026 under Trumpcare while federal deficits would go down by $119B over the coming decade.
New Stock Research Reports for Merck, 3M and United Technologies
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), 3M Co (MMM) and United Technologies Corporation (UTX).
Universal Health (UHS) Receives Rating Action from Moody's
by Zacks Equity Research
Universal Health Services, Inc. (UHS) has recently received rating action from Moody's Investors Service, a wing of Moody's Corp. (MCO)
Anthem Finally Walks Away from Cigna Merger, Seeks Charges
by Zacks Equity Research
Anthem Inc. (ANTM) has officially terminated its merger with Cigna.
Worried About Volatility? Buy these 5 Low Leverage Stocks
by Zacks Equity Research
Considering the fact that sudden variability can hit the global market any time, it is better to choose stocks that bear relatively less risk. One of the investment strategies to choose less risky stocks is to measure a company's debt level.
Aetna (AET) Calls it Quits on Unsustainable Public Exchanges
by Zacks Equity Research
In the wake of continued loss incurred by its public exchange business, health insurer Aetna Inc. (AET) has announced to pull back its presence.
Top Ranked Momentum Stocks to Buy for May 10th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 10th:
Teladoc (TDOC) Q1 Loss Lower Than Expected, '17 View Intact
by Zacks Equity Research
Teladoc Inc.'s (TDOC) operating loss of 30 cents per share came in narrower than the Zacks Consensus Estimate of a loss of 33 cents per share.
Cigna (CI) Beats on Q1 Earnings and Revenues, Guides Up
by Zacks Equity Research
Cigna (CI) earnings of $2.77 per share, comfortably beating the Zacks Consensus Estimate of $2.44.
Molina Healthcare (MOH) Q4 Earnings, Revenues Beat Estimates
by Zacks Equity Research
Molina Healthcare Inc. (MOH) reported first-quarter 2017 adjusted net income per share of $1.47 that surpassed the Zacks Consensus Estimate of 57 cents by 157%.
Stock Market News for May 05, 2017
by Zacks Equity Research
Benchmarks mostly ended flat on Thursday amid drop in oil prices and the first steps taken by House Republicans to repeal Obamacare
Trumpcare Gets House Support: What Next?
by Arpita Dutt
Although the House of Representatives voted to repeal Obamacare, will the Senate vote for Trumpcare in its current form?
Company News for May 04, 2017
by Zacks Equity Research
Companies in the News are: YUM,CLX,RAI,HUM
Humana (HUM) Beats on Earnings, Misses Revenues in Q1
by Zacks Equity Research
Humana Inc.'s (HUM) first-quarter 2017 operating earnings per share of $2.75 beat the Zacks Consensus Estimate by approximately 8%.
Humana's (HUM) Q1 Earnings Beat, Revenues Miss
by Anupama Mukhopadhyay
Humana (HUM) surpassed our earnings estimate. Our consensus called for EPS of $2.55, and the company reported EPS of $2.75.
Is a Surprise Coming for Humana (HUM) This Earnings Season?
by Zacks Equity Research
Humana (HUM) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.
Aetna (AET) Tops Q1 Earnings; Revenues Miss, Down Y/Y
by Zacks Equity Research
Aetna beats on earnings. Our consensus called for EPS of $2.36 and the company reported earnings per share of $2.71 and increased 17% year over year
Can CVS Health (CVS) Spring a Surprise this Earnings Season?
by Zacks Equity Research
CVS Health Corporation (CVS) is scheduled to report its first-quarter 2017 results before the opening bell on May 2.